| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/08/2011 | CN101491521B Medicine combination with diarrhea relieving function |
| 06/08/2011 | CN101480435B Hepatinica for Rachycentron canadum |
| 06/08/2011 | CN101474254B Chinese medicinal composition for treating chronic hepatitis B and preparation method thereof |
| 06/08/2011 | CN101474233B Atractylodes rhizome extract soft capsule and preparation method thereof |
| 06/08/2011 | CN101444582B Hepatitis B oral liquid |
| 06/08/2011 | CN101406486B Method for preparing maggot health-care oral liquid |
| 06/08/2011 | CN101367883B Method for extracting glossy ganoderma polysaccharide from fermentation liquor |
| 06/08/2011 | CN101361930B Male sexual function tonification health product and preparation method thereof |
| 06/08/2011 | CN101352552B Capsules for promoting children's intelligence, growth and development |
| 06/08/2011 | CN101341149B Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| 06/08/2011 | CN101314763B Short bifidobacteria with functions of anti-gastrointestinal tract pathogen, oxidation resistance and blood pressure reduction and its uses |
| 06/08/2011 | CN101301382B Externally used Chinese medicine for treating viral hepatitis jaundice and preparation thereof |
| 06/08/2011 | CN101301364B Externally used Chinese medicine for treating cirrhosis ascites and preparation thereof |
| 06/08/2011 | CN101272774B Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 06/08/2011 | CN101249251B Pharmaceutical combination for curing fatty liver and method of preparing the same |
| 06/08/2011 | CN101199644B External agent for treating vomit and prepared from pepper extract |
| 06/08/2011 | CN101198324B Cannabinoid active pharmaceutical ingredient for improved dosage forms |
| 06/08/2011 | CN101185481B Elver nuisance free swelling particle formula feed |
| 06/08/2011 | CN101130074B Medicament for treating and/or preventing hepatitis B |
| 06/08/2011 | CN101084971B Method for preparing total saponins of platycodon grandiflorum |
| 06/08/2011 | CN101080404B Pyrimidinylisoxazol derivative |
| 06/08/2011 | CN101062300B Compound traditional Chinese medicine preparation for treating virus hepatitis |
| 06/08/2011 | CN100998783B Traditional Chinese medicine composition capsule for treating gastrointestinal disease and its preparing method |
| 06/08/2011 | CA2724937A1 Medication for the treatment of gastrointestinal ulcers |
| 06/07/2011 | US7956187 Method for decreasing opioid metabolism |
| 06/07/2011 | US7956079 Antihepatitis C virus agent and anti-HIV agent |
| 06/07/2011 | US7956075 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/07/2011 | US7956045 Improving the health of ruminant animals, increasing milk production in lactating animals, and/or treating and controlling infective diarrhea by the oral administration of an effective amount of an indigestible oligosaccharide of gluco-oligosaccharides and/or isomalto-oligosaccharides; feed additives |
| 06/07/2011 | CA2785233A1 .beta.-carbolines for treatment of hearing damages and vertigo |
| 06/07/2011 | CA2555824C Fused-ring 4-oxopyrimidine derivative |
| 06/07/2011 | CA2483164C Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/07/2011 | CA2418422C Novel kallikrein gene |
| 06/07/2011 | CA2404431C Guanylyl cyclase c in the detection of stomach and esophageal cancers |
| 06/07/2011 | CA2386515C Piperazine derivatives |
| 06/07/2011 | CA2322954C Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 06/03/2011 | WO2011065552A1 Nutritional composition beneficial to small intestine |
| 06/03/2011 | WO2011064753A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | WO2011064376A1 Imidazole derivatives as aldosterone synthase inhibitors |
| 06/03/2011 | WO2011064350A1 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| 06/03/2011 | WO2011064297A1 Combination for the treatment of radiation - or chemotherapy - induced mucositis |
| 06/03/2011 | WO2011063753A1 Traditional chinese medicine composition for treating oral ulcer and tumor, preparation method and use thereof |
| 06/03/2011 | WO2011042501A3 Glp-2 for use in intestine and muscle recovery |
| 06/03/2011 | WO2011033225A3 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/03/2011 | CA2782177A1 Compressible-coated pharmaceutical compositions and tablets and methods of manufacture |
| 06/03/2011 | CA2782163A1 Ondansetron orally disintegrating tablet compositions for prevention of nausea and vomiting |
| 06/03/2011 | CA2781820A1 Combination for the treatment of radiation- or chemotherapy-induced mucositis |
| 06/03/2011 | CA2781451A1 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| 06/02/2011 | US20110130570 Novel Form of S-Omeprazole |
| 06/02/2011 | US20110130452 Store-operated calcium cellular assay |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130420 Isoquinolinone derivatives as nk3 antagonists |
| 06/02/2011 | US20110130415 Protein kinase c inhibitors and uses thereof |
| 06/02/2011 | US20110130409 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 06/02/2011 | US20110130407 Isoquinolinone derivatives as nk3 antagonists |
| 06/02/2011 | US20110130385 Bicyclic Heterocylic Derivatives and Methods of Use |
| 06/02/2011 | US20110130374 Small Pyrimidine Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110130368 Derivatives of 4- or 5-aminosalicylic acid |
| 06/02/2011 | US20110130366 Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations |
| 06/02/2011 | US20110130364 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/02/2011 | US20110130362 A2b adenosine receptor antagonists |
| 06/02/2011 | US20110130353 Highly purified antiendotoxin compound |
| 06/02/2011 | US20110130351 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity |
| 06/02/2011 | US20110130331 Modified growth hormones |
| 06/02/2011 | US20110130327 Multi-Arm Amines and Uses Thereof |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129543 Fermented plant extracts, methods of production and uses |
| 06/02/2011 | US20110129532 Method and means for treating viral disease, in particular hiv/aids |
| 06/02/2011 | US20110129530 Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture |
| 06/02/2011 | US20110129529 Probiotic products for pet applications |
| 06/02/2011 | US20110129504 Composition for controlling lipase catalyzed reactions |
| 06/02/2011 | US20110129469 Methods for treating fatty liver disease |
| 06/02/2011 | US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129451 Method for decreasing borborygmi by administering a bifidobacterium bacteria |
| 06/02/2011 | US20110129445 Combinations comprising methotrexate and dhodh inhibitors |
| 06/02/2011 | US20110129444 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 06/02/2011 | US20110129439 Conditioned medium of liver progenitor cells |
| 06/02/2011 | US20110129433 Compositions and Methods for Treating or Preventing Gastrointestinal Disorders and GERD-Related Respiratory Disorders |
| 06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 06/01/2011 | EP2327704A1 Ring-fused azole derivative having pi3k-inhibiting activity |
| 06/01/2011 | EP2327692A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors |
| 06/01/2011 | EP2327423A2 Human antibodies against human interleukin-22 (IL-22) |
| 06/01/2011 | EP2327422A1 Activin antagonists for diagnosis and therapy of diseases associated with fibrosis |
| 06/01/2011 | EP2327409A1 Tetracycline compound having target therapeutic activities |
| 06/01/2011 | EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy |
| 06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
| 06/01/2011 | EP2326645A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 06/01/2011 | EP2326343A2 Pancreatic polypeptide and variants thereof for use in the treatment of intestinal disorders |
| 06/01/2011 | EP2326317A1 Guanylhydrazones for treatment of postoperative intestinal inflammation |
| 06/01/2011 | EP1337525B1 Process for the crystallization of (r)- or (s)-lansoprazole |
| 06/01/2011 | CN102083854A Glycosylated GLP-1 peptide |
| 06/01/2011 | CN102083810A Activator for peroxisome proliferator-activated receptor |
| 06/01/2011 | CN102083799A Benzimidazole derivatives used as FXR agonists |
| 06/01/2011 | CN102083433A Treatment of hepatitis c virus infections with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha-2A/2B and ribavirin |
| 06/01/2011 | CN102083431A Use of cyclolignans for the treatment of a hyperactive immune system |
| 06/01/2011 | CN102079821A Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof |
| 06/01/2011 | CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof |
| 06/01/2011 | CN102078616A Esomeprazole sodium bicarbonate composition |
| 06/01/2011 | CN102078615A Composition of proton pump inhibitor and gastric mucosa protective agent |